Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
24 Jun 2019 Which Neoadjuvant Treatment Strategy for High-Risk Resectable Melanoma? Melanoma and other skin tumours - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
21 Jun 2019 BLU-667 in RET-driven NSCLC and Thyroid Cancer Lung and other thoracic tumours - Endocrine and neuroendocrine tumours - Personalised medicine - Anticancer agents & Biologic therapy
19 Jun 2019 FDA Approves Pembrolizumab for Metastatic Small Cell Lung Cancer Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
19 Jun 2019 Five-Year Survival Data in Advanced NSCLC Treated with Pembrolizumab Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
18 Jun 2019 Five-Year Outcomes with Combination Targeted Therapy in Metastatic Melanoma Melanoma and other skin tumours - Anticancer agents & Biologic therapy
17 Jun 2019 EMA Starts Review of Leuprorelin Medicines Anticancer agents & Biologic therapy
14 Jun 2019 FDA Approves Polatuzumab Vedotin-piiq for DLBCL Haematologic malignancies - Anticancer agents & Biologic therapy
13 Jun 2019 Pembrolizumab in PD-L1-positive, HER2-negative Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma Gastrointestinal cancers - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
13 Jun 2019 FDA Approves Pembrolizumab for First-line Treatment of HNSCC Head and neck cancers - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
12 Jun 2019 Multi-omics Study of Gut Microbiota in Colorectal Cancer Gastrointestinal cancers - Translational research - Epidemiology/Etiology/Cancer Prevention
11 Jun 2019 Triple Combined Therapy in BRAF-Mutated Melanoma Melanoma and other skin tumours - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
07 Jun 2019 FDA Approves Lenalidomide for Follicular and Marginal Zone Lymphoma Haematologic malignancies - Anticancer agents & Biologic therapy
06 Jun 2019 Targeting DNA Repair in Metastatic Pancreatic and Prostate Cancers Gastrointestinal cancers - Genitourinary cancers - Personalised medicine - Anticancer agents & Biologic therapy
05 Jun 2019 FDA Approves Addition of Survival Data to Gilteritinib Label for Refractory AML With a FLT3 Mutation Haematologic malignancies - Personalised medicine - Anticancer agents & Biologic therapy
04 Jun 2019 GITR Is an Attractive Target for Immunotherapy Cancer Immunology and Immunotherapy